Home Relationships between Serum Markers of Monocyte/Macrophage Activation in Type 1 Gaucher's Disease
Article
Licensed
Unlicensed Requires Authentication

Relationships between Serum Markers of Monocyte/Macrophage Activation in Type 1 Gaucher's Disease

  • J. Antonio Casal , Lúcia Lacerda , Luis F. Pérez , Rui A. Pinto , M. Clara Sá Miranda and J. Carlos Tutor
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 40 Issue 1

Abstract

We studied 44 patients with type 1 Gaucher's disease (16 non-treated patients and 28 treated with enzyme replacement therapy). We measured serum levels of chitotriosidase (ChT), neopterin, angiotensin-converting enzyme (ACE), adenosine deaminase (ADA) and β-hexosaminidase (Hex) and its major isoenzymes Hex A and Hex B. In the untreated group of patients, the increase in serum levels was ChT>neopterin>ACE>ADA>Hex, with all decreasing significantly in treated patients (p<0.001). Highly significant correlations were obtained between the markers of monocyte/macrophage activation which were tested (p<0.001). However, partial correlations between serum Hex B (with Hex A constant) and ChT, ACE, neopterin and ADA did not reach statistical significance. This suggests that hepatocytes are the major cellular source of this isoenzyme. Similarly, partial correlation of ChT with neopterin, with the other variables constant, was not significant, which would suggest a different expression of these two markers in Gaucher's disease.

:
Published Online: 2005-06-01
Published in Print: 2002-01-29

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Editorial
  2. Growing Significance of Myeloperoxidase in Non-infectious Diseases
  3. Serum Paraoxonase Activity and the Extent of Lipid Peroxidation Are not Affected by Increased Levels of Human Apolipoprotein A-I: Studies in Transgenic Mice
  4. Relationship between the Sialic Acid Content of Low-Density Lipoprotein (LDL) and Autoantibodies to Oxidized LDL in the Plasma of Healthy Subjects and Patients with Atherosclerosis
  5. The Presence of Heparin-Platelet Factor 4 Antibodies as a Marker of Hypercoagulability during Hemodialysis
  6. Clinical Evaluation of Changes in the Morphology of Eosinophils
  7. The n-3 and n-6 Polyunsaturated Fatty Acid Composition of Plasma Phospholipids in Pregnant Women and Their Infants. Relationship with Maternal Linoleic Acid Intake
  8. Quantification of Sirolimus by Liquid Chromatography-Tandem Mass Spectrometry Using On-Line Solid-Phase Extraction
  9. The Effects of Affinity-Purified Anti-DNA Antibodies Derived from Patients with Systemic Lupus Erythematosus on the Fluorescent Antinuclear Antibody Assay Using HEp-2 Cells
  10. Relationships between Serum Markers of Monocyte/Macrophage Activation in Type 1 Gaucher's Disease
  11. Gender Differences in C-Reactive Protein Concentrations - Confirmation with Two Sensitive Methods
  12. Serum Cholinesterase Activity in Patients with Burns
  13. Serum Lipids and Apolipoproteins in Patients with Psoriasis
  14. Reference Intervals for a Complete Blood Count Determined on different Automated Haematology Analysers: Abx Pentra 120 Retic, Coulter Gen-S, Sysmex SE 9500, Abbott Cell Dyn 4000 and Bayer Advia 120
  15. Science, Alchemy and Light: Paintings by Joseph Wright of Derby
  16. Approved IFCC Reference Method for the Measurement of HbA1c in Human Blood
  17. Meetings and Awards
Downloaded on 10.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.010/html
Scroll to top button